Quest Diagnostics Inc
Slēgts
SektorsVeselības aprūpe
193.88 -2.04
Pārskats
Akcijas cenas izmaiņa
24h
Min
193.27
Max
194.96
Ienākumi | 19M 264M |
|---|---|
Pārdošana | 89M 2.9B |
P/E Sektora vidējais | 22.316 49.712 |
EPS | 2.5 |
Dividenžu ienesīgums | 1.61 |
Peļņas marža | 9.119 |
Darbinieki | 57,000 |
EBITDA | 33M 434M |
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | +14.43% upside |
Dividenžu ienesīgums Sektora vidējais | 1.61% 2.36% |
|---|---|
Nākamie ieņēmumi | 2026. g. 23. jūl. |
Nākamais dividenžu datums | 2026. g. 22. jūl. |
Nākamais Ex dividenžu datums | 2026. g. 8. jūl. |
Tirgus kapitalizācija | 652M 22B |
|---|---|
Iepriekšējā atvēršanas cena | 195.92 |
Iepriekšējā slēgšanas cena | 193.88 |
Ziņu noskaņojums
By Acuity
50%
50%
123 / 342 Rangs Healthcare
Quest Diagnostics Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.